These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 16709308

  • 21. Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK.
    Roze S, Valentine WJ, Zakrzewska KE, Palmer AJ.
    Diabet Med; 2005 Sep; 22(9):1239-45. PubMed ID: 16108855
    [Abstract] [Full Text] [Related]

  • 22. Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes.
    Roze S, Saunders R, Brandt AS, de Portu S, Papo NL, Jendle J.
    Diabet Med; 2015 May; 32(5):618-26. PubMed ID: 25483869
    [Abstract] [Full Text] [Related]

  • 23. Applying some UK Prospective Diabetes Study results to Switzerland: the cost-effectiveness of intensive glycaemic control with metformin versus conventional control in overweight patients with type-2 diabetes.
    Palmer AJ, Sendi PP, Spinas GA.
    Schweiz Med Wochenschr; 2000 Jul 11; 130(27-28):1034-40. PubMed ID: 10953853
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
    Clarke P, Gray A, Adler A, Stevens R, Raikou M, Cull C, Stratton I, Holman R, UKPDS Group. United Kingdom Prospective Diabetes Study.
    Diabetologia; 2001 Mar 11; 44(3):298-304. PubMed ID: 11317659
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Impact of self-measurement of blood glucose on complications of type 2 diabetes: economic analysis from a Czech perspective.
    Weber C, Kocher S, Neeser K, Bartaskova D.
    Curr Med Res Opin; 2010 Feb 11; 26(2):289-96. PubMed ID: 19947908
    [Abstract] [Full Text] [Related]

  • 36. Cost effectiveness of ACE inhibitor treatment for patients with type 1 diabetes mellitus.
    Dong FB, Sorensen SW, Manninen DL, Thompson TJ, Narayan V, Orians CE, Gregg EW, Eastman RC, Dasbach EJ, Herman WH, Newman JM, Narva AS, Ballard DJ, Engelgau MM.
    Pharmacoeconomics; 2004 Feb 11; 22(15):1015-27. PubMed ID: 15449965
    [Abstract] [Full Text] [Related]

  • 37. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.
    CDC Diabetes Cost-effectiveness Group.
    JAMA; 2002 May 15; 287(19):2542-51. PubMed ID: 12020335
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cost-effectiveness of highly purified omega-3 polyunsaturated fatty acid ethyl esters in the treatment of chronic heart failure: results of Markov modelling in a UK setting.
    Cowie MR, Cure S, Bianic F, McGuire A, Goodall G, Tavazzi L.
    Eur J Heart Fail; 2011 Jun 15; 13(6):681-9. PubMed ID: 21474462
    [Abstract] [Full Text] [Related]

  • 40. Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose and intermittently scanned continuous glucose monitoring in people with type 1 diabetes receiving multiple daily insulin injections in Denmark.
    Alshannaq H, Cogswell G, Pollock RF, Ahmed W, Norman GJ, Lynch PM, Roze S.
    Diabetes Obes Metab; 2023 Sep 15; 25(9):2704-2713. PubMed ID: 37334522
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.